Index RUT
P/E -
EPS (ttm) -6.31
Insider Own 2.40%
Shs Outstand 55.95M
Perf Week 39.14%
Market Cap 2.49B
Forward P/E -
EPS next Y -5.76
Insider Trans -13.80%
Shs Float 55.41M
Perf Month 26.75%
Income -352.62M
PEG -
EPS next Q -1.60
Inst Own 109.06%
Short Float 10.98%
Perf Quarter 36.24%
Sales 29.40M
P/S 84.63
EPS this Y -1.03%
Inst Trans -2.91%
Short Ratio 8.48
Perf Half Y 97.17%
Book/sh 13.11
P/B 3.34
EPS next Y 9.91%
ROA -35.24%
Short Interest 6.08M
Perf Year 70.48%
Cash/sh 10.53
P/C 4.16
EPS next 5Y 39.00%
ROE -39.61%
52W Range 19.80 - 39.70
Perf YTD 96.81%
Dividend Est. -
P/FCF -
EPS past 5Y -0.98%
ROI -44.25%
52W High 10.40%
Beta 0.77
Dividend TTM -
Quick Ratio 12.39
Sales past 5Y 2.66%
Gross Margin 59.90%
52W Low 121.42%
ATR (14) 2.23
Dividend Ex-Date -
Current Ratio 12.84
EPS Y/Y TTM -58.92%
Oper. Margin -1336.41%
RSI (14) 73.31
Volatility 8.67% 4.81%
Employees 383
Debt/Eq 0.09
Sales Y/Y TTM 54.61%
Profit Margin -1199.26%
Recom 1.29
Target Price 50.20
Option/Short Yes / Yes
LT Debt/Eq 0.07
EPS Q/Q 1.34%
Payout -
Rel Volume 2.82
Prev Close 36.34
Sales Surprise -2.01%
EPS Surprise 12.00%
Sales Q/Q 46.00%
Earnings May 02 BMO
Avg Volume 717.27K
Price 43.83
SMA20 27.69%
SMA50 37.91%
SMA200 65.57%
Trades
Volume 2,025,835
Change 20.61%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-08-24 Initiated
Cantor Fitzgerald
Overweight
Feb-03-23 Initiated
Piper Sandler
Overweight
$41
Nov-17-22 Upgrade
Goldman
Sell → Neutral
$17 → $32
Jul-27-22 Upgrade
SVB Leerink
Mkt Perform → Outperform
$33
Dec-03-21 Initiated
BofA Securities
Buy
$54
Jul-30-21 Downgrade
Goldman
Neutral → Sell
$58 → $39
Jul-01-21 Initiated
Raymond James
Mkt Perform
Jun-10-21 Initiated
H.C. Wainwright
Buy
$88
Mar-01-21 Upgrade
SVB Leerink
Mkt Perform → Outperform
$50
Mar-01-21 Downgrade
JP Morgan
Overweight → Neutral
$64 → $54
Feb-26-21 Downgrade
SVB Leerink
Outperform → Mkt Perform
Oct-22-20 Upgrade
Barclays
Equal Weight → Overweight
$46
Mar-04-20 Initiated
Barclays
Equal Weight
$50
Nov-26-19 Initiated
Cantor Fitzgerald
Overweight
$64
Sep-23-19 Upgrade
Guggenheim
Neutral → Buy
$55
May-23-19 Resumed
Goldman
Neutral
$55
Feb-15-19 Upgrade
SVB Leerink
Mkt Perform → Outperform
$80
Sep-25-18 Initiated
Leerink Partners
Mkt Perform
May-23-18 Initiated
Citigroup
Buy
$117
Apr-11-18 Reiterated
Credit Suisse
Outperform
$80 → $95
Show Previous Ratings
Today 06:30AM
May-30-24 04:05PM
May-29-24 12:35PM
May-28-24 04:03PM
(Investor's Business Daily) +23.21%
12:20PM
(Associated Press Finance)
09:46AM
Loading…
09:46AM
(Investor's Business Daily)
08:12AM
07:00AM
May-24-24 09:55AM
May-14-24 10:00AM
May-08-24 09:55AM
May-06-24 07:00AM
May-03-24 12:21PM
11:10AM
07:00AM
03:03AM
Loading…
03:03AM
May-02-24 10:45PM
(Thomson Reuters StreetEvents)
12:57PM
11:56AM
08:44AM
08:25AM
07:29AM
(Associated Press Finance)
07:00AM
Apr-25-24 10:02AM
Apr-18-24 07:00AM
Apr-16-24 04:30PM
Apr-10-24 07:01PM
Apr-09-24 07:00AM
Mar-05-24 07:00AM
Feb-26-24 03:12PM
(Investor's Business Daily)
10:45AM
Loading…
Feb-23-24 10:45AM
(Investor's Business Daily) +10.78%
Feb-22-24 07:00AM
Feb-20-24 08:24AM
Feb-16-24 09:38AM
Feb-15-24 10:15PM
(Thomson Reuters StreetEvents)
08:25AM
07:59AM
07:00AM
Feb-08-24 10:00AM
Feb-02-24 07:00AM
Jan-24-24 07:02PM
Jan-11-24 07:15PM
Jan-08-24 07:00AM
Jan-04-24 11:19AM
07:47AM
Jan-03-24 04:05PM
(Investor's Business Daily) +5.21%
02:46PM
(The Wall Street Journal)
02:01PM
(The Wall Street Journal)
10:09AM
(Investor's Business Daily)
09:26AM
(Investor's Business Daily)
06:58AM
06:40AM
06:30AM
Jan-02-24 07:00AM
Dec-09-23 07:00PM
Nov-21-23 10:56AM
Nov-20-23 07:00AM
Nov-03-23 12:10PM
11:06AM
Nov-02-23 09:32AM
09:05AM
07:10AM
(Associated Press Finance)
07:00AM
Oct-19-23 07:00AM
Sep-07-23 11:30AM
Aug-29-23 07:00AM
Aug-10-23 06:08AM
(American City Business Journals)
Aug-04-23 05:32PM
09:10AM
06:04AM
Aug-03-23 11:53PM
(Thomson Reuters StreetEvents)
07:55AM
06:54AM
06:35AM
06:30AM
Jul-18-23 09:55AM
Jul-17-23 09:55AM
Jul-13-23 07:00AM
Jun-28-23 09:40AM
Jun-27-23 01:47PM
Jun-26-23 02:23PM
06:30AM
Jun-12-23 09:55AM
Jun-05-23 07:00AM
May-30-23 09:45AM
May-25-23 09:55AM
07:00AM
May-11-23 10:00AM
May-09-23 09:55AM
May-08-23 07:55AM
May-05-23 10:50AM
May-04-23 11:23PM
(Thomson Reuters StreetEvents) +7.65%
08:25AM
07:00AM
Apr-25-23 07:00AM
Apr-19-23 07:00AM
Apr-13-23 07:00AM
Apr-12-23 08:00AM
Apr-09-23 01:19PM
Apr-03-23 07:00AM
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
FOUSE JACQUALYN A Director Apr 10 '24 Sale 27.55 7,791 214,642 137,396 Apr 10 04:03 PM FOUSE JACQUALYN A Director Apr 08 '24 Option Exercise 0.00 15,934 0 145,187 Apr 10 04:03 PM Foster-Cheek Kaye I Director Mar 07 '24 Sale 31.62 1,285 40,632 5,524 Mar 11 04:09 PM Foster-Cheek Kaye I Director Mar 06 '24 Sale 31.99 4,415 141,236 6,809 Mar 07 06:49 PM Goff Brian Chief Executive Officer Mar 05 '24 Sale 32.57 4,156 135,361 53,780 Mar 05 04:10 PM Burns James William Chief Legal Officer Mar 05 '24 Sale 32.57 2,642 86,050 34,518 Mar 05 04:08 PM Gheuens Sarah Chief Medical Officer Mar 05 '24 Sale 32.57 2,642 86,050 36,415 Mar 05 04:20 PM Washburn Theodore James Jr. Principal Accounting Officer Mar 05 '24 Sale 31.75 1,913 60,738 2,886 Mar 07 06:47 PM Washburn Theodore James Jr. Principal Accounting Officer Mar 05 '24 Sale 32.57 1,214 39,540 3,368 Mar 05 04:15 PM Jones Cecilia Chief Financial Officer Mar 05 '24 Sale 32.57 672 21,887 14,840 Mar 05 04:18 PM Foster-Cheek Kaye I Director Mar 05 '24 Sale 32.21 300 9,663 11,224 Mar 07 06:49 PM Washburn Theodore James Jr. Principal Accounting Officer Mar 01 '24 Option Exercise 0.00 3,127 0 5,718 Mar 05 04:15 PM Goff Brian Chief Executive Officer Mar 01 '24 Option Exercise 0.00 8,500 0 57,936 Mar 05 04:10 PM Burns James William Chief Legal Officer Mar 01 '24 Option Exercise 0.00 7,834 0 38,518 Mar 05 04:08 PM Gheuens Sarah Chief Medical Officer Mar 01 '24 Option Exercise 0.00 7,834 0 40,415 Mar 05 04:20 PM Jones Cecilia Chief Financial Officer Mar 01 '24 Option Exercise 0.00 2,000 0 15,512 Mar 05 04:18 PM Schenkein David P Director Feb 27 '24 Option Exercise 31.64 69,329 2,193,570 180,325 Feb 29 04:05 PM Schenkein David P Director Feb 27 '24 Sale 34.67 69,329 2,403,592 122,854 Feb 29 04:05 PM Schenkein David P Director Feb 26 '24 Option Exercise 31.64 20,411 645,804 143,265 Feb 27 04:04 PM Schenkein David P Director Feb 26 '24 Sale 33.19 20,411 677,441 122,854 Feb 27 04:04 PM Schenkein David P Director Feb 23 '24 Option Exercise 31.64 47,731 1,510,209 170,585 Feb 27 04:04 PM Schenkein David P Director Feb 23 '24 Sale 33.05 47,731 1,577,510 122,854 Feb 27 04:04 PM Washburn Theodore James Jr. Principal Accounting Officer Feb 20 '24 Sale 26.63 504 13,422 2,741 Feb 22 05:43 PM Gheuens Sarah Chief Medical Officer Feb 14 '24 Sale 25.14 642 16,140 33,431 Feb 14 05:53 PM Burns James William Chief Legal Officer Feb 14 '24 Sale 25.14 545 13,701 31,666 Feb 14 05:51 PM Washburn Theodore James Jr. Principal Accounting Officer Feb 14 '24 Sale 25.14 273 6,863 3,245 Feb 14 05:50 PM Gheuens Sarah Chief Medical Officer Feb 12 '24 Option Exercise 0.00 2,162 0 34,073 Feb 14 05:53 PM Burns James William Chief Legal Officer Feb 12 '24 Option Exercise 0.00 1,833 0 32,211 Feb 14 05:51 PM Washburn Theodore James Jr. Principal Accounting Officer Feb 12 '24 Option Exercise 0.00 777 0 3,518 Feb 14 05:50 PM FOUSE JACQUALYN A Director Jan 24 '24 Sale 21.64 10,722 232,024 129,253 Jan 24 04:22 PM Goff Brian Chief Executive Officer Jan 24 '24 Sale 21.64 7,635 165,221 49,436 Jan 24 04:20 PM Jones Cecilia Chief Financial Officer Jan 24 '24 Sale 21.64 1,886 40,813 13,069 Jan 24 04:23 PM Gheuens Sarah Chief Medical Officer Jan 24 '24 Sale 21.64 1,708 36,961 31,911 Jan 24 04:24 PM Burns James William Chief Legal Officer Jan 24 '24 Sale 21.64 1,708 36,961 30,378 Jan 24 04:25 PM Milanova Tsveta Chief Commercial Officer Jan 24 '24 Sale 21.64 1,618 35,014 13,234 Jan 24 04:19 PM Burns James William Chief Legal Officer Jan 20 '24 Option Exercise 0.00 5,750 0 32,086 Jan 24 04:25 PM Gheuens Sarah Chief Medical Officer Jan 20 '24 Option Exercise 0.00 5,750 0 33,619 Jan 24 04:24 PM Jones Cecilia Chief Financial Officer Jan 20 '24 Option Exercise 0.00 5,380 0 14,955 Jan 24 04:23 PM FOUSE JACQUALYN A Director Jan 20 '24 Option Exercise 0.00 23,900 0 139,975 Jan 24 04:22 PM Milanova Tsveta Chief Commercial Officer Jan 20 '24 Option Exercise 0.00 5,448 0 14,852 Jan 24 04:19 PM Goff Brian Chief Executive Officer Jan 20 '24 Option Exercise 0.00 17,018 0 57,071 Jan 24 04:20 PM Goff Brian Chief Executive Officer Jan 09 '24 Sale 22.99 12,066 277,397 40,053 Jan 09 04:28 PM FOUSE JACQUALYN A Director Jan 09 '24 Sale 22.99 8,391 192,909 116,075 Jan 09 04:26 PM Gheuens Sarah Chief Medical Officer Jan 09 '24 Sale 22.99 1,789 41,129 27,869 Jan 09 04:22 PM Burns James William Chief Legal Officer Jan 09 '24 Sale 22.99 1,163 26,737 26,336 Jan 09 04:25 PM FOUSE JACQUALYN A Director Jan 05 '24 Option Exercise 0.00 17,500 0 124,466 Jan 09 04:26 PM Burns James William Chief Legal Officer Jan 05 '24 Option Exercise 0.00 3,250 0 27,499 Jan 09 04:25 PM Gheuens Sarah Chief Medical Officer Jan 05 '24 Option Exercise 0.00 5,000 0 29,658 Jan 09 04:22 PM Goff Brian Chief Executive Officer Jan 05 '24 Option Exercise 0.00 25,527 0 52,119 Jan 09 04:28 PM Milanova Tsveta Chief Commercial Officer Jan 05 '24 Sale 22.32 2,902 64,773 9,404 Jan 05 04:10 PM Milanova Tsveta Chief Commercial Officer Jan 03 '24 Option Exercise 0.00 8,475 0 12,306 Jan 05 04:10 PM Jones Cecilia Chief Financial Officer Sep 28 '23 Sale 24.79 2,179 54,017 9,575 Sep 28 04:02 PM Jones Cecilia Chief Financial Officer Sep 26 '23 Option Exercise 0.00 7,472 0 11,754 Sep 28 04:02 PM Burns James William Chief Legal Officer Aug 17 '23 Sale 26.28 6,395 168,061 23,890 Aug 21 04:03 PM Ballal Rahul D. Director Aug 11 '23 Option Exercise 0.00 2,302 0 2,302 Aug 15 04:06 PM Smith Cynthia Director Aug 11 '23 Option Exercise 0.00 2,302 0 2,302 Aug 15 04:04 PM Foster-Cheek Kaye I Director Aug 09 '23 Option Exercise 18.09 25,000 452,250 36,524 Aug 11 04:04 PM Foster-Cheek Kaye I Director Aug 09 '23 Sale 25.96 25,000 648,888 11,524 Aug 11 04:04 PM Goff Brian Chief Executive Officer Aug 08 '23 Option Exercise 0.00 22,691 0 36,770 Aug 10 04:07 PM Goff Brian Chief Executive Officer Aug 08 '23 Sale 25.48 10,178 259,335 26,592 Aug 10 04:07 PM Washburn Theodore James Jr. Principal Accounting Officer Aug 07 '23 Sale 25.39 2,918 74,096 2,741 Aug 09 04:04 PM Washburn Theodore James Jr. Principal Accounting Officer Aug 01 '23 Option Exercise 0.00 4,150 0 6,891 Aug 02 04:02 PM Washburn Theodore James Jr. Principal Accounting Officer Aug 01 '23 Sale 26.26 1,232 32,352 5,659 Aug 02 04:02 PM Goff Brian Chief Executive Officer Jun 30 '23 Sale 28.36 11,449 324,694 14,079 Jun 30 04:05 PM FOUSE JACQUALYN A Director Jun 30 '23 Sale 28.36 10,718 303,962 106,966 Jun 30 04:07 PM Burns James William Chief Legal Officer Jun 30 '23 Sale 28.36 1,707 48,411 30,285 Jun 30 04:09 PM Gheuens Sarah Chief Medical Officer Jun 30 '23 Sale 28.36 1,707 48,411 24,159 Jun 30 04:06 PM Milanova Tsveta Chief Commercial Officer Jun 30 '23 Sale 28.36 1,618 45,886 3,831 Jun 30 04:02 PM Jones Cecilia Chief Financial Officer Jun 30 '23 Sale 28.36 1,597 45,291 3,783 Jun 30 04:03 PM Milanova Tsveta Chief Commercial Officer Jun 28 '23 Option Exercise 0.00 5,449 0 5,449 Jun 30 04:02 PM Jones Cecilia Chief Financial Officer Jun 28 '23 Option Exercise 0.00 5,380 0 5,380 Jun 30 04:03 PM FOUSE JACQUALYN A Director Jun 28 '23 Option Exercise 0.00 23,900 0 117,684 Jun 30 04:07 PM Goff Brian Chief Executive Officer Jun 28 '23 Option Exercise 0.00 25,528 0 25,528 Jun 30 04:05 PM Gheuens Sarah Chief Medical Officer Jun 28 '23 Option Exercise 0.00 5,750 0 25,866 Jun 30 04:06 PM Burns James William Chief Legal Officer Jun 28 '23 Option Exercise 0.00 5,750 0 31,992 Jun 30 04:09 PM Schenkein David P Director Jun 21 '23 Option Exercise 0.00 4,975 0 122,854 Jun 23 04:34 PM Foster-Cheek Kaye I Director Jun 21 '23 Option Exercise 0.00 4,975 0 11,524 Jun 23 04:38 PM Ho Maykin Director Jun 21 '23 Option Exercise 0.00 4,975 0 11,524 Jun 23 04:37 PM Scadden David Director Jun 21 '23 Option Exercise 0.00 4,975 0 12,095 Jun 23 04:36 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite